HOME Research Insight New Products is Another Major Factor Driving the Growth of the Autoimmune Disease Diagnosis Market.



New Products is Another Major Factor Driving the Growth of the Autoimmune Disease Diagnosis Market.


The global autoimmune disease diagnosis market is expected to reach USD 4.73 Billion by 2022 from USD 3.09 Billion in 2017, at a CAGR of 8.9%. Factors driving the growth of this market include high incidence and large economic burden of autoimmune diseases, increasing healthcare expenditure, and growing access to medical insurance in the US.

The development of new products is another major factor driving the growth of the autoimmune disease diagnosis market. The continuous development of products provides end users with advanced options for autoimmune disease diagnostics and treatment. The use of advanced analyzers for the diagnosis are gaining popularity in the autoimmune disease diagnosis market. This technique has revolutionized the autoimmune disease diagnosis process as it provides easy, rapid, and efficient processing.

On the basis of product and service, the autoimmune disease diagnosis market is categorized into consumables & assay kits, instruments, and services. The consumables & assay kits segment is expected to grow at the fastest rate during the forecast period. The requirement of consumables in large numbers as compared to instruments is the main factor contributing to the high growth rate of this segment.

Based on test type, the autoimmune disease diagnosis market has been segmented into routine laboratory tests, inflammatory markers, autoantibodies and immunologic tests, and other tests. The routine laboratory tests segment is expected to account for the largest share of the market in 2017. The increasing adoption of routine tests for the diagnosis of several diseases is driving the growth of the market.

Based on disease, the autoimmune disease diagnosis market has been segmented into systemic lupus erythematosus, rheumatoid arthritis, Sjögren’s syndrome, thyroiditis, scleroderma, and other diseases. In 2017, the rheumatoid arthritis segment is expected to account for the largest share of the autoimmune disease diagnosis market. The increasing incidence of rheumatoid arthritis is driving the growth of the market.

By end user, the autoimmune disease diagnosis market is classified into clinical laboratories, hospitals, and other end users. The hospitals and clinics segment is estimated to grow at the fastest rate during the forecast period. The developing healthcare infrastructure and the rising number of diagnostic tests performed in hospitals are driving the demand for autoimmune disease diagnosis products.

The autoimmune disease diagnosis market is geographically segmented into North America, Europe, Asia, and the Rest of the World (RoW). Asia is expected to have the highest growth rate due to the heavy burden of autoimmune diseases, improving healthcare infrastructure, and rising awareness about the use of diagnostics in the region.

Given the immense opportunities in major applications like the diagnosis of a large number of diseases, market leaders and emerging players are increasingly focusing on the market in the segments mentioned above to increase their revenues and are also looking to expand their reach to emerging economies.

Related Reports:

Autoimmune Disease Diagnosis Market by Products (Consumables, Assay Kits, Instruments, Services), Test Type (Inflammatory Markers, Autoantibodies), Disease (RA, SLE, Thyroiditis, Scleroderma), End Users (Hospitals, Clinical Labs) - Global Forecast to 2022

Contact:
Mr. Rohan
MarketsandMarkets™ INC. 
630 Dundee Road 
Suite 430 
Northbrook, IL 60062 
USA : 1-888-600-6441 
sales@marketsandmarkets.com

Connect Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441

Search reports